Rethinking Clinical Trials

FEBRUARY 28, 2024

            Speakers Adrian Hernandez, MD Executive Director, Duke Clinical Research Institute Vice Dean, Duke University School of Medicine Christopher J. The global decentralized clinical trial market is expected to grow at a compound annual growth rate of 30.1% from 2021 to 2026.

Clinical Trials 141

Clinical Trials Clinical Trials Trials Clinical Research 141

pharmaphorum

APRIL 26, 2021

The goal of the partnership for approval for the Japanese market from the Pharmaceuticals and Medical Devices Agency (PMDA). It also develops services to support the evolution of medical care and finding purposes in life, in collaboration with various research institutions and companies.

Development 121

Development Medicine Production Marketing 121

pharmaphorum

AUGUST 17, 2020

N o one industry is ever quite like another, but there are some valuable lessons for pharma marketing from examining how the financial sector uses technology, builds brands on social channels and approaches digital content. Engagement channels. Joanna Carlish.

Regulation 97

Regulation Marketing Sales Branding 97

Rethinking Clinical Trials

JULY 6, 2023

This guidance and others in development in other markets act as an important countermeasure to ensuring sustained adoption and implementation of DCTs. The DCT space is evolving and will require more commentary on guidance, sharing research, and effective implementation. Learn more Read more about Decentralized Clinical Trials.

Trials 130

Trials Clinical Trials Clinical Trials Licensing 130

XTalks

JULY 16, 2021

But yet, the price tag is still higher than real meat. Well, much like any company operating in the free market, plant-based meat producers like Beyond Meat and Impossible Foods want to turn a profit and that might involve charging consumers as much as they are willing to pay. Turning a Profit. Supply Chain. R&D Costs. Scaling Up.

Protein 105

Protein Production Manufacturing Branding 105

Pharmaceutical Technology

FEBRUARY 22, 2023

Both drugs come with a high price tag. Amgen won the initial trial in March 2016 and Sanofi faced a potential withdrawal of Praluent from the US market. In its past statements shared with other outlets, Amgen stated that patents need to give researchers wide protection to incentivise new inventions.

Antibody 262

Antibody Drugs Sales Protein 262

XTalks

NOVEMBER 3, 2022

In its first quarter on the market since its approval, sales totalled $97 million between July and September in the US. Novo’s Ozempic shortage may also challenge Lilly’s “ability to meet expanding demand [for Trulicity] in most international markets,” Ashkenazi explained. In the third quarter of 2022, Mounjaro scored $187.3

Sales 98

Sales FDA Approval Production Insulin 98

XTalks

OCTOBER 28, 2021

According to a report from Grand View Research, the global vegan baking ingredients market size was valued at $1.1 However, while Brave Robot’s cake mix is technically animal-free, it is unclear whether it will fit into this market or whether it deserves a market of its own. percent from 2019 to 2025.

Protein 98

Protein Packaging Packaging DNA 98

Roots Analysis

JANUARY 28, 2024

Velocity: Big Data needs to be handled promptly as businesses generate data at an unprecedented speed, driven by the growing adoption of Internet of Things (IoT), and technologies, such as RFID tags, sensors, and smart meters are used to deal with the high velocity of data in real-time. It is loosely arranged into categories using meta tags.

Big Data 40

Big Data Medicine Marketing Clinical Trials 40

pharmaphorum

DECEMBER 23, 2021

Researchers have hypothesised that inhibiting EGFR and HER3 in tandem could lead to greater efficiency and also overcome resistance to currently available EGFR-directed drugs. The post FDA gives Daiichi Sankyo’s HER3 drug a breakthrough tag appeared first on. Daiichi Sankyo and AZ are close collaborators in the ADC arena.

Drugs 71

Drugs Antibody Clinical Trials Clinical Trials 71

The Pharma Data

MARCH 16, 2022

The research scientist at the Max Planck Institute for Medical Research received the award in recognition of his ground-breaking work in establishing various approaches to protein labeling in living cells that have enabled far-reaching advances in chemical and cell biology. Protein labeling (e.g. Protein labeling (e.g.

Protein 52

Protein Scientist Gene Development 52

XTalks

JULY 12, 2021

head of research and development at Biogen, in a statement from the company. Experts like Bernstein analyst Ronny Gal said it was an “almost shockingly broad” label that would give Biogen unwarranted market access to the approximately 6 million Alzheimer’s sufferers in the US.

Drugs 98

Drugs Clinical Trials Clinical Trials Trials 98

Delveinsight

FEBRUARY 9, 2021

Deerfield and Dana-Farber Establish Links in USD 130 Million Cancer Research Deal. Deerfield Management has entered into a research agreement with Dana-Farber Cancer Institute to fuel the development of therapeutics and diagnostics for cancer. European Marketing Authorisation to ViiV Healthcare’s Rukobia for Multidrug-resistant HIV.

FDA Approval 52

FDA Approval Marketing Research Protein 52

Drug Discovery World

JANUARY 30, 2024

Lentivirus strategies are one of the most widely used tools in biomedical research and clinical testing, says Stella Vnook, CEO, Likarda. “Dr Other Challenges: Limited insurance coverage: Many insurance companies are hesitant to cover CGTs due to their high price tags and limited long-term data.

Gene Therapy 71

Gene Therapy Manufacturing Gene Clinical Trials 71

pharmaphorum

JANUARY 21, 2022

This evolution is leading to additional health benefits and health gains, but they are accompanied by major concerns, as very high price tags raise questions about their affordability.”. In recent years, revolutionary medicines have come with price tags to match, but this is simply a symptom of our current model.

Medicine 52

Medicine Marketing Manufacturing Production 52

XTalks

JANUARY 7, 2022

Even LEANguini comes at a higher price tag since it commands an $8 to $10 surcharge when substituted in any made-to-order dish. According to Research and Markets , the global health and wellness food market size was estimated at $95.56 billion in 2020 and is expected to reach $162.06 percent. .

Protein 52

Protein Marketing Containment Branding 52

pharmaphorum

DECEMBER 23, 2022

price tag of $475,000 when it was first launched in 2017 – and it becomes apparent that these may not be desirable treatment options for every patient and in every setting. Add to this the considerable cost of these medications – the first approved CAR-T, Novartis’ Kymriah (tisagenlecleucel), had a U.S. Oral therapy data presented at ASH.

Development 52

Development Drugs Clinical Development Antibody 52

pharmaphorum

JUNE 8, 2021

Instead, the FDA granted Aduhelm a conditional approval, allowing it to be prescribed and used while Biogen conducts a post-marketing, phase 4 confirmatory study – which could take years to complete. If benefit is not verified, we can act to remove the drug from the market. — Brad Loncar (@bradloncar) June 7, 2021.

Drugs 98

Drugs Marketing FDA Approval Trials 98

pharmaphorum

JUNE 2, 2022

Evaluate Pharma’s recent Orphan Drug Report subtitled its overview of the market ‘Niche no longer.’ The report estimates that the orphan drug market will grow twice as fast as the non-orphan market, with a 2021 to 2026 compound annual growth rate of 12%. The price is right. Raising questions. Reaching a compromise.

Drugs 52

Drugs Sales Marketing Development 52

Drug Discovery World

MAY 22, 2023

Large pharma involvement in advanced therapies has seen ebbs and flows, with AstraZeneca taking a larger stake in the market and Takeda developing its automation and digital capabilities, but also with GSK letting go of its CGT projects, along with most of the staff involved in its R&D. But are these price tags a barrier to access?

Gene Therapy 52

Gene Therapy Gene Drugs Contamination 52

XTalks

JUNE 8, 2021

With a price tag of over $2.5 The researchers conducted a long-term follow-up study of the START trial that included patients who completed phase I of the study. Given that SMA is a rare condition, a specialized drug had to be created for it, which required intense research and the right expertise.

Gene Therapy 110

Gene Therapy Gene Protein Trials 110

Drug Discovery World

JANUARY 10, 2023

Scientists purchase antibodies with the expectation that they will recognise their intended targets and produce reliable data, but the presence of improperly validated antibodies on the market can make this process both time-consuming and expensive. Pillar 5: Protein OE/Epitope Tags. Pillar 4: Biological Characteristics.

Antibody 52

Antibody Protein Reagent Scientist 52

XTalks

JUNE 9, 2021

million Alzheimer’s patients in the US, some market goers are apprehensive about the implications this could have for the industry. Aducanumab Controversy and Price Tag. Along with the approval, Biogen also announced the drug’s steep $56,000 per year list price, which is several times higher than what industry analysts were expecting.

Drugs 98

Drugs Clinical Trials Clinical Trials Trials 98

Delveinsight

FEBRUARY 23, 2021

The company plans to use the capital to expand its pipeline of protein-based vaccines and biologic cancer therapies utilizing its innovative and proprietary Trimer-Tag technology platform. The company, however, is optimistic and gearing up to find more opportunities to advance in the ALS market. LightDeck Diagnostics Gets USD 5.65

In-Vitro 52

In-Vitro Vaccination Vaccine Licensing 52

pharmaphorum

DECEMBER 2, 2020

Their follow-up to penicillin, Terramycin, first marketed in 1950, was both their first proprietary drug, and the first for which the company used sales reps, their soon to be formidable force of salesmen starting with just eight members. . Antibiotics marked the transition to the modern Pfizer.

Sales 128

Sales Production Drugs Marketing 128

The Pharma Data

OCTOBER 21, 2020

In a trial of 63 patients, researchers found that the drug regimen frequently wiped out all signs of the cancer — a subtype of the blood cancer acute lymphoblastic leukemia (ALL). At that point, 95% were still alive, and 88% were free of a relapse, according to the researchers led by Dr. Robin Foa, of the University of Rome.

Drugs 52

Drugs Genetics Trials Research 52

The Pharma Data

OCTOBER 21, 2020

In a trial of 63 patients, researchers found that the drug regimen frequently wiped out all signs of the cancer — a subtype of the blood cancer acute lymphoblastic leukemia (ALL). At that point, 95% were still alive, and 88% were free of a relapse, according to the researchers led by Dr. Robin Foa, of the University of Rome.

Drugs 52

Drugs Genetics Trials Research 52

Delveinsight

JULY 22, 2020

New Insight/Data For Research. The data collected in the IoT can support medical research. The hospital inventory is equipped with tagged sensors. What are the driving forces behind the IoT device market in healthcare? Research and Development in the IT field. Medical Equipment Tracking. Growing Aging population.

Doctors 59

Doctors Doctor Marketing Production 59

pharmaphorum

JANUARY 31, 2023

With the recent rapid rollout of Covid-19 vaccines, many people have raised questions about whether adequate research was conducted on these vaccines before approval. What people did not understand was that “fast tracking” approval does not limit the rigorous process involved in ensuring that a medication or vaccine is safe for market use.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Vaccination 52

pharmaphorum

NOVEMBER 16, 2022

Only a few years later, bluebird bio’s gene therapy, Zynteglo (betibeglogene autotemcel), was approved in the European market for the treatment of the rare blood disorder, beta thalassaemia. However, with a price tag of €1.58 How to navigate the new climate. At more than $2.1

Gene Therapy 131

Gene Therapy Gene Marketing Development 131

XTalks

FEBRUARY 27, 2024

Rare Disease Day 2024, which falls on February 29 this year, is an opportunity to unite under a common cause: to bring attention to the challenges faced by those living with rare diseases and to push for advancements in research, treatment and policy. Sarepta hopes to clarify Elvidys’ effectiveness in older children in a confirmatory trial.

Research 59

Research Drugs Gene Therapy Clinical Trials 59

Pharma Marketing Network

OCTOBER 4, 2020

Don ( PMN): Hello everyone thanks for joining us at the Pharma marketing podcast. He’s a serial entrepreneur, a search engine marketing evangelist and a passionate networker. So I wanted to talk a little bit about that and how are our listeners can leverage the topic you cover in this book for their own marketing efforts.

Doctors 52

Doctors Doctor Marketing Packaging 52

XTalks

AUGUST 23, 2021

This is not a debate on approval,” said Stacie Weninger, PhD, president of the F-Prime Biomedical Research Initiative, in a focused topic session on the impact of drug approval on future clinical trials held on Tuesday July 27. With a $56,000 price tag for a year’s worth of treatment, Aduhelm is far from the most expensive drug on the market.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Drugs 52

Pharmaceutical Technology

JANUARY 27, 2023

Dr. James George, a research professor at the University of Oklahoma Health Sciences Center, said Cablivi “adds a new aspect to treatment, the prompt recovery of platelets and prompt resolution of transient neurologic symptoms”. The disorder has a reported annual incidence between 1.5 cases per million in Europe.

Manufacturing 130

Manufacturing Drugs Research Analyst FDA Approval 130

XTalks

AUGUST 19, 2022

XTALKS WEBINAR: How Agile Clinical Trials Unlock Universal Access to Rare Disease Research. Zynteglo’s hefty price tag of $2.8 In a press release , bluebird said the approval of Zynteglo is “the culmination of nearly ten years of clinical research of gene therapy in patients with transfusion-dependent beta-thalassemia.”.

Gene Therapy 95

Gene Therapy FDA Approval Gene Clinical Trials 95

The Pharma Data

NOVEMBER 15, 2020

Cytiva provides FlexFactory bioprocessing upstream and downstream solutions for Clover to accelerate GMP facility development and shorten time to market. Clover aims to double its commercial manufacturing capacity in preparation for global Phase 2/3 trials. SHANGHAI , Nov.

Vaccination 52

Vaccination Vaccine Manufacturing Life Science 52

Roots Analysis

SEPTEMBER 13, 2023

These molecules can be conjugated with various modalities, such as haptens, enzymes, isotopes, fluorescent tags, carrier proteins, polymers, particle conjugates and photoreactive molecules. Bioconjugation is a subset of conjugation where one of the entity is a biomolecule, such as protein or an antibody.

Development 40

Development Antibody Protein Drug Delivery Systems 40